✦ LIBER ✦

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

✍ Scribed by E. Guardiola; F. Peyrade; L. Chaigneau; D. Cupissol; X. Tchiknavorian; E. Bompas; A. Madroszyk; P. Ronchin; M. Schneider; J.P. Bleuze; J.Y. Blay; X. Pivot

Book ID: 116428255
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 171 KB
Volume: 40
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2004.05.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Weekly Docetaxel and C

Phase II Study of Weekly Docetaxel and Cisplatin in Patients With Advanced Recurrent and Metastatic Head and Neck Cancer

✍ Orlando Guntinas-Lichius; Stefan Appenrodt; Florian Veelken; Barbara Krug 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

A phase II study of piritrexim in combin

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

✍ Everett E. Vokes; Isaiah W. Dimery; Charlotte D. Jacobs; Daniel Karp; Arturo Mol 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

Thirty patients with recurrent and/or metastatic head and neck cancer were treated with sequentially administered methotrexate (MTX) and piritrexim (PTX). The treatment schedule consisted of intravenous (IV) MTX (50 mg/m') administered on day 1 and oral PTX (75 mg/mz) administered twice daily on day

Phase II study of docetaxel and topoteca

Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer

✍ RobertI. Haddad; DavidA. Echo 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 161 KB

Docetaxel and epirubicin compared with d

Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study

✍ Petrioli, R; Pascucci, A; Conca, R; Chiriacò, G; Francini, E; Bargagli, G; Fiasc 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 322 KB

Phase II study with IL-2 combined with v

Phase II study with IL-2 combined with vincristine, bleomycin, and methotrexate (VBM) in recurrent head and neck carcinomas

✍ G. Gambaro; P. Bagnasacco; A. Ballarè; L. Turri; A. Prino; G. Oro; M. Krengli 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase II study of sunitinib in patient

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

✍ George Fountzilas; Anna Fragkoulidi; Anna Kalogera-Fountzila; Martha Nikolaidou; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 639 KB